pone.0222221.g004.tif (198.97 kB)
Cumulative incidences of retreatment according to end-of treatment HBsAg levels in HBeAg-negative patients.
figure
posted on 2019-10-04, 17:28 authored by Te-Ling Ma, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Chien-Hung ChenCumulative incidences of retreatment according to end-of treatment HBsAg levels in HBeAg-negative patients.
History
Usage metrics
Categories
Keywords
CHBHBV genotype BHBeAg-positive patients375 HBeAg-negative patientstenofovir treatment BackgroundDiscontinuing TDF treatmentbaseline HBsAg levelsETV5- year retreatment rateHBeAg-negative patientsend-of-treatment HBsAg levels160 hepatitis B e antigenTDF treatmentrelapseNational Health Planhepatitis B patientsMultivariate Cox regression analysisretreatment criteriatenofovir disoproxil fumarate
